Literature DB >> 21799273

Estimation of cardiac event risk by gated myocardial perfusion imaging and quantitative scoring methods based on a multi-center J-ACCESS database.

Kenichi Nakajima1, Shinro Matsuo, Koichi Okuda, Hiroshi Wakabayashi, Kazumasa Tsukamoto, Tsunehiko Nishimura.   

Abstract

BACKGROUND: Myocardial perfusion imaging (MPI) has been used to estimate cardiac event risk. The aim of the present study is to achieve stable risk estimation based on perfusion scoring and a multi-center prognostic database. METHODS AND
RESULTS: Multivariate logistic regression analysis was performed to estimate cardiac event risk based on a J-ACCESS study. A stress-MPI was performed in 45 patients with coronary artery disease (CAD) and in 25 non-CAD patients. Perfusion defect scoring of summed stress score (SSS) was performed by 5 methods: (1) visual scoring; (2) automatic scoring of 3 short-axis and 1 vertical long-axis slices; (3) visual modification of Method 2; (4) automatic polar map scoring based on a Japanese multi-center database; and (5) visual modification of Method 4. Agreement of SSS between 2 observers was good (r=0.87-0.97). Agreement of estimated cardiac event risk between observers and among 5 methods was very good (r=0.99-1.00). Regarding diagnostic accuracy for CAD, Method 5 showed optimal diagnostic yields (sensitivity 84%, accuracy 77%).
CONCLUSIONS: Estimation of cardiac event risk in conjunction with polar map segmentation and common normal databases resulted in stable risk values, and might be used for risk stratification in patients suspected of having CAD.

Entities:  

Mesh:

Year:  2011        PMID: 21799273     DOI: 10.1253/circj.cj-11-0371

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Better characterization of dipyridamole-induced myocardial stunning by systolic wall thickening. A gated perfusion SPECT study.

Authors:  Alberto Bestetti; Besart Cuko; Massimo Gasparini; Stefano De Servi
Journal:  J Nucl Cardiol       Date:  2018-06-27       Impact factor: 5.952

2.  Quantification of the myocardial area at risk using coronary CT angiography and Voronoi algorithm-based myocardial segmentation.

Authors:  Akira Kurata; Atsushi Kono; Tsuyoshi Sakamoto; Teruhito Kido; Teruhito Mochizuki; Hiroshi Higashino; Mitsunori Abe; Adriaan Coenen; Raluca G Saru-Chelu; Pim J de Feyter; Gabriel P Krestin; Koen Nieman
Journal:  Eur Radiol       Date:  2014-08-31       Impact factor: 5.315

3.  Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database.

Authors:  Shinro Matsuo; Kenichi Nakajima; Yasuchika Takeishi; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

4.  Prognostic risk stratification based on left ventricular mechanical dyssynchrony in patients at low or intermediate risk of major cardiac events using the J-ACCESS risk model.

Authors:  Masatsugu Miyagawa; Shunichi Yoda; Hidesato Fujito; Takumi Hatta; Yudai Tanaka; Katsunori Fukumoto; Yasuyuki Suzuki; Naoya Matsumoto; Yasuo Okumura
Journal:  Heart Vessels       Date:  2022-08-12       Impact factor: 1.814

5.  Seeing is believing: Visualization of multivariable risk models.

Authors:  Kenichi Nakajima; Hayato Tada
Journal:  J Nucl Cardiol       Date:  2022-09-12       Impact factor: 3.872

6.  Additional value of systolic wall thickening in myocardial stunning evaluated by stress-rest gated perfusion SPECT.

Authors:  Alberto Bestetti; Besart Cuko; Adriano Decarli; Alessio Galli; Federico Lombardi
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

7.  Prognostic value of automated SPECT scoring system for coronary artery disease in stress myocardial perfusion and fatty acid metabolism imaging.

Authors:  Tomoaki Nakata; Akiyoshi Hashimoto; Takayuki Matsuki; Keiichiro Yoshinaga; Kazumasa Tsukamoto; Nagara Tamaki
Journal:  Int J Cardiovasc Imaging       Date:  2012-07-11       Impact factor: 2.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.